ISHI Islet Holdings Inc (CE)

Islet Holdings, Inc. (Pink Sheets:ISHI)(“the Company”) recently announced that the Company would expand its business plan to pursue additional and new medical technologies and products. Today the Company announced that it has added the development, production, and sales of cannabidiol (CBD) oil to its business plan. CBD is one of approximately 85 cannabinoids present in the Cannabis plant.

Use of CBDs is spreading nationwide for treating medical needs of patients experiencing chronic seizures. CBDs may be extracted from either hemp or marijuana plants, both of which are Cannabis plants. Hemp is the term generally used for tall-growing varieties of the Cannabis plant and is produced for products such as hemp seed foods, hemp oil, wax, rope, cloth, pulp, paper and fuel. Additionally, the hemp plant is bred for a nearly non-existent presence of THC. Cannabis sativa, however, commonly known as marijuana, are plants bred for and used for psychoactive drug qualities.

The production and processing of CBDs depends on what Cannabis plant is utilized. CBD extraction from marijuana plants require elimination of relatively high quantities of THC through the breeding process. Through long-term breading, however, the hemp plant contains minimal, if not negligible, amounts of THC.

CBDs are an entirely separate category from “medical cannabis” products, which generally retain psychoactive agents. In connection with this new business opportunity, J. Michael Heil, Director and CEO of the Company, stated, “Not to be confused with the marijuana plant itself, CBDs that have less than .3% THC are legal in states throughout the United States. The Company will obtain CBDs from domestically grown hemp plants to further assure our planned and stringent quality controls from planting to packaging. Many people are suffering today needlessly. We intend to meet their needs through natural and organic products.”

The Company intends produce CBDs for wholesale and retail sales and plans to establish strategic alliances and arrangements prior to the end of the year in furthering its business plan.

Release Note: Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements. The realization of any or all of these expectations is subject to a number of risks and uncertainties and it is possible that the assumptions made by management may not materialize.

Islet Holdings, Inc.Mike Heil, 303-587-1435

Islet (CE) (USOTC:ISHI)
Historical Stock Chart
From Oct 2024 to Nov 2024

Islet (CE) (USOTC:ISHI)
Historical Stock Chart
From Nov 2023 to Nov 2024